Jeff Yass’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,023
Closed -$302K – 14641
2026
Q2
$302K Buy
+8,023
New +$278K ﹤0.01% 11025
2023
Q4
– Sell
-507
Closed -$9.7K – 13394
2023
Q3
$9.7K Sell
507
-1,399
-73% -$34.2K ﹤0.01% 11721
2023
Q2
$56.4K Buy
1,906
+1,524
+399% +$48.4K ﹤0.01% 11286
2023
Q1
$12.3K Buy
+382
New +$13K ﹤0.01% 12164
2022
Q4
– Sell
-556
Closed -$22K – 13798
2022
Q3
$22K Buy
556
+39
+8% +$1.54K ﹤0.01% 12575
2022
Q2
$16K Sell
517
-61
-11% -$1.56K ﹤0.01% 12417
2022
Q1
$17K Buy
+578
New +$17.3K ﹤0.01% 12671
2021
Q3
– Sell
-1,069
Closed -$97K – 13663
2021
Q2
$97K Buy
+1,069
New +$108K ﹤0.01% 12112
2020
Q2
– Sell
-407
Closed -$31K – 11012
2020
Q1
$31K Buy
+407
New +$39.1K ﹤0.01% 9824
2017
Q1
– Sell
-307
Closed -$59K – 10068
2016
Q4
$59K Buy
+307
New +$70.6K ﹤0.01% 9250
2015
Q4
– Sell
-548
Closed -$143K – 10047
2015
Q3
$143K Buy
+548
New +$191K ﹤0.01% 8958

Other funds holding VTVT

Jeff Yass's VTVT Position: Q3 2026 in Review

Jeff Yass sold out of vTv Therapeutics (VTVT) in Q3 2026, closing a stake of 8,023 shares — an estimated $302K sold.

Jeff Yass first reported a position in VTVT in Q3 2015 and held it in 11 quarters. The position peaked at $302K in Q2 2026. 38 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.

  • Jeff Yass reported no remaining vTv Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 8,023 vTv Therapeutics shares in Q3 2026, an estimated $302K.
  • Jeff Yass first reported a position in vTv Therapeutics in Q3 2015 and held it in 11 quarters.
  • Jeff Yass's vTv Therapeutics position peaked at $302K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.